|
gptkbp:instanceOf
|
gptkb:brand
gptkb:drug
|
|
gptkbp:activeIngredient
|
gptkb:triazolam
|
|
gptkbp:antidote
|
gptkb:flumazenil
|
|
gptkbp:approvedBy
|
1982
|
|
gptkbp:ATCCode
|
N05CD05
|
|
gptkbp:broadcastOn
|
Schedule IV (US)
|
|
gptkbp:CASNumber
|
28911-01-5
|
|
gptkbp:cause
|
dependence
withdrawal symptoms
|
|
gptkbp:chemicalFormula
|
C17H12Cl2N4
|
|
gptkbp:contraindication
|
pregnancy
severe liver disease
hypersensitivity to benzodiazepines
|
|
gptkbp:drugClass
|
benzodiazepine
|
|
gptkbp:eliminatedIn
|
urine
|
|
gptkbp:halfLife
|
1.5-5.5 hours
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Halcion
|
|
gptkbp:interactsWith
|
gptkb:beer
CYP3A4 inhibitors
other CNS depressants
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Pfizer
|
|
gptkbp:marketedIn
|
gptkb:Australia
gptkb:Canada
gptkb:Japan
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:notRecommendedFor
|
children
elderly (caution)
long-term use
|
|
gptkbp:overdoseSymptoms
|
coma
respiratory depression
death (rare)
|
|
gptkbp:pregnancyCategory
|
gptkb:X_(US)
|
|
gptkbp:prescribes
|
short-term treatment of insomnia
|
|
gptkbp:riskFactor
|
tolerance
anterograde amnesia
paradoxical reactions
next-day impairment
rebound insomnia
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
gptkb:center
dizziness
headache
drowsiness
coordination problems
|
|
gptkbp:usedFor
|
insomnia
|
|
gptkbp:withdrawn
|
gptkb:Brazil
gptkb:Netherlands
gptkb:Norway
|
|
gptkbp:bfsParent
|
gptkb:Upjohn
|
|
gptkbp:bfsLayer
|
5
|